Future Projections: Anticoccidial Drugs Market to Reach $1.75 Million by 2029 at 6.5% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Anticoccidial Drugs Market Valued at Present and by 2029?
In recent times, the market size for anticoccidial drugs has been on a steady incline. Approximately, the market value will increase from $1.27 billion in 2024 to $1.35 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The notable growth during the historic period can be linked to several factors such as the worldwide surge in coccidiosis cases, a rise in pet ownership, a high occurrence rate of coccidiosis, economic ramifications, and escalated worries about the health and food safety of animals.
The market for anticoccidial drugs is poised for significant expansion in the approaching years, projected to reach a worth of “$1.75 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.5%. Various factors fueling this predicted growth include the increase in veterinary healthcare, the escalating incidences of coccidiosis in animals, the proliferation in the usage of synthetic drugs, the rising demand for feed additives, and enhancing livestock production. Key trends that will define this timeframe include a heightened demand due to new strains of coccidiosis, a shift towards natural and alternative treatment strategies, spurred innovation due to rigorous regulatory oversight, elevated consumer desire for poultry products free of antibiotics, advancements in drug administration techniques, a sharper focus on preventative healthcare measures, and new applications in the aquaculture and companion animal sectors.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp
#What Drivers Are Influencing Growth In The Anticoccidial Drugs Market?
The escalation in the need for meat proteins is anticipated to boost the anticoccidial drug market’s expansion in the future. Naturally found in animal flesh, meat proteins consist of diverse essential amino acids for various metabolic processes. The surge in demand for these proteins is attributed to population growth, increased disposable income, urbanization, and a shift in dietary preferences towards food rich in proteins. Anticoccidial pharmaceuticals play a crucial role in modern livestock farming; they aid in preserving the health and productivity of animals, enabling farmers to cater to the escalating demand for meat proteins effectively and sustainably. As an illustration, in July 2023, a report by the France-based intergovernmental organization, the Organization for Economic Co-operation and Development (OECD), and the Food and Agriculture Organization, an Italy-based specialized agency, noted that, opposed to the anticipated 2% rise in global average per capita meat demand from 2020-2022 to 2032, the FAO meat price index skyrocketed by 10% in 2022 owing to reduced export supplies. Consequently, the surging demand for meat proteins fuels the growth of the anticoccidial drug market.
The anticoccidial drugs market covered in this report is segmented –
1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine
What Upcoming Trends Are Expected To Impact The Anticoccidial Drugs Market Globally?
Leading corporations in the anticoccidial drugs market are concentrating on creating novel solutions like synthetic coccidiostats. These solutions aim to augment effectiveness, reduce the development of resistance, and meet the rising complications in poultry and livestock management. Synthetic coccidiostat, a specially crafted chemical compound, is aimed at controlling or preventing coccidiosis by restricting the growth and duplication of coccidia parasites in the animals. For instance, in March 2023, Avi-Deccox, a revamped synthetic coccidiostat was launched by Zoetis, a US-based animal health corporation. The product is intended to check coccidiosis in broiler chickens specifically, while primarily targeting the Eimeria acervulina and Eimeria tenella pathogens, associated with substantial financial losses in poultry farming. The active ingredient in this product, similar to its precursor, Deccox, is decoquinate. By using a unique mode of action, Avi-Deccox manages the escalating problem of resistance resulting from the regular usage of ionophores in poultry farming and offers a more efficacious immediate effect.
Which Companies Play A Key Role In The Development Of The Anticoccidial Drugs Market?
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report
What Are The Key Regional Developments Shaping The Anticoccidial Drugs Market?
North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
